United States - English - NLM (National Library of Medicine)

padagis us llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 g - for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms: escherichia coli, staphylococcus aureus, staphylococcus pneumonia, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species . topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeroginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. hypersensitivity to sulfonamides or to any ingredient of the preparation.

Canada - English - Health Canada

odan laboratories ltd - sulfacetamide sodium - solution - 10% - sulfacetamide sodium 10% - antibacterials

Canada - English - Health Canada

allergan inc - sulfacetamide sodium; prednisolone acetate - ointment - 10%; 0.2% - sulfacetamide sodium 10%; prednisolone acetate 0.2% - sulfonamides

Canada - English - Health Canada

odan laboratories ltd - sulfacetamide sodium; prednisolone acetate - solution - 100mg; 5mg - sulfacetamide sodium 100mg; prednisolone acetate 5mg - sulfonamides

Canada - English - Health Canada

allergan inc - sulfacetamide sodium; prednisolone acetate - drops - 10%; 0.2% - sulfacetamide sodium 10%; prednisolone acetate 0.2% - sulfonamides

United States - English - NLM (National Library of Medicine)

bi-coastal pharma international llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - sodium sulfacetamide 10% and sulfur 2% cleanser is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide 10% and sulfur 2% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% and sulfur 2% cleanser is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

bi-coastal pharma international llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 98 mg in 1 g - indications: sodium sulfacetamide 9.8% and sulfur 4.8% cleanser is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 9.8% and sulfur 4.8% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 9.8% and sulfur 4.8% cleanser is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

e. fougera & co., a division of nycomed us inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 g - sodium sulfacetamide medicated pads are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide medicated pads are contraindicated in persons with known or suspected hypersensitivity to sulfonamides or to any of the ingredients of the preparation. sodium sulfacetamide medicated pads are not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - indications and usage: sodium sulfacetamide 10% cleansing gel is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). it also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides. contraindications: sodium sulfacetamide 10% cleansing gel is contraindicated in persons with known or suspected hypersensitivity to sulfonamides or to any of the ingredients of the product. pediatric use: safety and effectiveness in children under the age of 12 years has not been established.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 9 mg in 1 g - indications: sodium sulfacetamide 9% - sulfur 4.5% wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 9% - sulfur 4.5% wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or ony other component of this preparation. sodium sulfacetamide 9% - sulfur 4.5% wash is not to be used by patients with kidney disease.